category:news
Are GLP1s primarily brain drugs?
Are GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc) primarily brain drugs?
category:news
company:eli-lilly
Eli Lilly China approval and new suppliers
As the race to manufacture more GLP1 medications intensifies, Eli Lilly gets approval in China and more suppliers.
drug:danuglipron
Pfizer's GLP1: Danuglipron
Read more about Dangulipron, Pfizer's GLP1 receptor agonist. Will it be better than Ozempic, Wegovy, Mounjaro, Zepbound and others?
category:news
Victoza (Liraglutide) Generic hits the market
Teva Pharmaceuticals has started manufacturing a Victoza generic drug (liraglutide), and it's available inside the United States.
category:news
Nestle's Vital Pursuit for GLP1 users
The trend of companies riding the GLP1 wave continues -- Nestle introduces a new food line that is aimed at attracting GLP1 users.
chemical:servodutide
Survodutide Phase 2 Trial Results
Survodutide is a dual Glucagon and Glucagon-Like Peptide 1 agonist which interacts with hormone receptors in your body to help reduce food cravings, and encourage weight loss. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out our quick explainer
user:senior-citizens
Senior citizens and GLP1 Receptor Agonists
Senior citizens are adopting and starting to use GLP1 Receptor Agonists in droves. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out our quick explainer Based on data from 2023, over 1 in 4 people who were on Ozempic
drug:wegovy
FDA approves Wegovy for reducing heart disease risk
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or OverweightThe FDA approved a new use for a drug to reduce the risk of serious heart problems in adults with cardiovascular disease and either obesity or overweight.FDAOffice of the Commissioner In great